Literature DB >> 16022964

Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood.

Gertie C M Beaufort-Krol1, Maarten P van den Berg, Arthur A M Wilde, J Peter van Tintelen, Jan Willem Viersma, Connie R Bezzina, Margreet Th E Bink-Boelkens.   

Abstract

OBJECTIVES: The aim was to investigate at what age electrocardiographic characteristics of long QT syndrome type 3 (LQT3) and Brugada syndrome (BS), based on a single SNC5A mutation, appear.
BACKGROUND: The QT interval (QT) in LQT3 is prolonged during bradycardia. It is not clear yet if this is obvious in young children with a relative fast heart rate (HR).
METHODS: Thirty-six children with an SNC5A gene mutation (1795insD) and 46 non-carrier siblings were investigated. In different age groups, HR, QT, QTc, and ST-segment elevation on a 12-lead electrocardiogram (ECG), and HR, QT, QTc, and DeltaQT after the longest pause in a Holter (recording) were evaluated.
RESULTS: In all age groups, HR at rest tended to be lower in carriers than in non-carriers, and QT was longer in carriers than in non-carriers. The Brugada phenotype was found >5 years. Gender specific differences were not identified. The QT at lower HR and DeltaQT were longer in carriers than in non-carriers. A QTc of > or =0.44 s at the lowest HR (sensitivity 100%; specificity 88.4%) and DeltaQT > or =60 ms (sensitivity 100%; specificity 82.6%) were good predictors for having LQT3.
CONCLUSIONS: We conclude that electrocardiographic characteristics of LQT3 and BS show age-dependent penetrance. A QT prolongation and conduction disease were present from birth onwards, whereas ST-segment elevation only developed >5 years. Good tools for clinical diagnosis of LQT3 in this family are QTc at the lowest HR and DeltaQT after a pause in a Holter, even at very young age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16022964     DOI: 10.1016/j.jacc.2005.03.066

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

Review 1.  Brugada syndrome in childhood: a potential fatal arrhythmia not always recognised by paediatricians. A case report and review of the literature.

Authors:  Yvan Mivelaz; Stefano Di Bernardo; Etienne Pruvot; Erik Jan Meijboom; Nicole Sekarski
Journal:  Eur J Pediatr       Date:  2006-05-03       Impact factor: 3.183

Review 2.  The year 2005 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

3.  Rhythm dynamics of the aging heart: an experimental study using conscious, restrained mice.

Authors:  Martina Comelli; Marianna Meo; Daniel O Cervantes; Emanuele Pizzo; Aaron Plosker; Peter J Mohler; Thomas J Hund; Jason T Jacobson; Olivier Meste; Marcello Rota
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-04       Impact factor: 4.733

4.  Functional characterization of a novel SCN5A variant associated with long QT syndrome and sudden cardiac death.

Authors:  Jacqueline Neubauer; Zizun Wang; Jean-Sébastien Rougier; Hugues Abriel; Claudine Rieubland; Deborah Bartholdi; Cordula Haas; Argelia Medeiros-Domingo
Journal:  Int J Legal Med       Date:  2019-08-27       Impact factor: 2.686

5.  A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations.

Authors:  Krekwit Shinlapawittayatorn; Xi X Du; Haiyan Liu; Eckhard Ficker; Elizabeth S Kaufman; Isabelle Deschênes
Journal:  Heart Rhythm       Date:  2010-11-23       Impact factor: 6.343

6.  Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.

Authors:  Kirstine Calloe; Nicole Schmitt; Soren Grubb; Ryan Pfeiffer; Jens-Peter David; Ronald Kanter; Jonathan M Cordeiro; Charles Antzelevitch
Journal:  Can J Physiol Pharmacol       Date:  2011-09-06       Impact factor: 2.273

7.  Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide.

Authors:  P G Postema; M Van den Berg; J P Van Tintelen; F Van den Heuvel; M Grundeken; N Hofman; W P Van der Roest; E A Nannenberg; I P C Krapels; C R Bezzina; A Wilde
Journal:  Neth Heart J       Date:  2009-11       Impact factor: 2.380

8.  Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome.

Authors:  Ibrahim El-Battrawy; Gretje Roterberg; Kim Schlentrich; Volker Liebe; Siegfried Lang; Boris Rudic; Erol Tülümen; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Pediatr Cardiol       Date:  2019-11-20       Impact factor: 1.655

9.  Mechanisms underlying age-associated manifestation of cardiac sodium channel gain-of-function.

Authors:  Madison B Nowak; Steven Poelzing; Seth H Weinberg
Journal:  J Mol Cell Cardiol       Date:  2020-12-26       Impact factor: 5.000

10.  Ventricular Tachyarrhythmia Risk in Paediatric/Young vs. Adult Brugada Syndrome Patients: A Territory-Wide Study.

Authors:  Sharen Lee; Wing Tak Wong; Ian Chi Kei Wong; Chloe Mak; Ngai Shing Mok; Tong Liu; Gary Tse
Journal:  Front Cardiovasc Med       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.